Drug Warning: Mobic
Generic name: meloxicam (class of drugs known as NSAIDs)
Manufactured and marketed by: Abbott Laboratories
Purpose: Prescribed to patients suffering from the symptoms of rheumatoid arthritis and osteoarthritis, which may include swelling, inflammation, stiffness, and joint pain.
Side Effects Reported
- NSAIDs have been linked to liver damage.
- Patients taking NSAIDs, including Mobic, should be aware of the symptoms of liver damage which include yellow coloring of the skin or eyes, dark urine, fatigue, nausea, vomiting, loss of appetite, and flu like symptoms.
NSAIDs may also be linked to cardiovascular problems including heart attack and stroke. In addition, NSAIDs may be associated with an increased risk of hypertension, congestive heart failure, and edema. NSAIDs as a class are also linked to gastrointestinal problems including bleeding and ulceration.
Seeger Weiss is not currently pursuing lawsuits on this drug, but its drug warnings will remain on our radar.Free Case Evaluation
Philadelphia, PA –Christopher A. Seeger, Co-Lead Counsel for the retired NFL player plaintiffs in In Re: National Football League Players Concussion Injury Litigation, responded today to the Court’s granting of final approval [...]April 30, 2015 By: Seeger Weiss LLP read more
Seeger Weiss LLP is currently investigating claims that Bard’s Recovery IVC Filter and G2 IVC Filter Systems are defective and prone to dangerous fractures and migration. In 2009, lawsuits were file on [...]April 13, 2015 By: Seeger Weiss LLP read more